Thurston Springer Miller Herd & Titak’s Pfizer PFE Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.4K	Sell	3,422 -251	-7%	-$6.57K	0.03%	383
2026 Q1	$103K	Buy	3,673 +77	+2%	+$2.05K	0.04%	371
2025 Q4	$89.6K	Buy	3,596 +1,162	+48%	+$29.3K	0.03%	379
2025 Q3	$62K	Sell	2,434 -22,601	-90%	-$558K	0.12%	188
2025 Q2	$607K	Buy	25,035 +2,858	+13%	+$66.7K	0.08%	221
2025 Q1	$562K	Sell	22,177 -527	-2%	-$13.8K	0.09%	182
2024 Q4	$602K	Sell	22,704 -570	-2%	-$15.5K	0.12%	164
2024 Q3	$674K	Buy	23,274 +5,205	+29%	+$152K	0.19%	135
2024 Q2	$506K	Buy	+18,069	New	+$497K	0.16%	142

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's PFE Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak reduced its Pfizer (PFE) stake by 6.8% in Q2 2026, selling an estimated $6.57K and leaving 3,422 shares worth $82.4K. The position accounts for 0.03% of the portfolio, ranked #383.

Thurston Springer Miller Herd & Titak first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $674K in Q3 2024. 1,091 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Thurston Springer Miller Herd & Titak held 3,422 shares of Pfizer worth $82.4K as of Q2 2026.
Thurston Springer Miller Herd & Titak sold 251 Pfizer shares in Q2 2026, an estimated $6.57K.
Pfizer made up 0.03% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #383 holding.
Thurston Springer Miller Herd & Titak first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
Thurston Springer Miller Herd & Titak's Pfizer position peaked at $674K in Q3 2024.
1,091 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.